Stay updated on Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial
Sign up to get notified when there's something new on the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page.

Latest updates to the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe record now presents details for the completed BETWEEN study, including its design, eligibility criteria, treatment arms, outcomes, locations, and study documents, instead of an error page.SummaryDifference49%

- Check15 days agoChange DetectedThe NIH announcement about terminology changes from “Artificial Intelligence” to “Super Intelligence” was removed. The site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference1%

- Check22 days agoChange DetectedA site-wide notice about NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” appears above the study page content.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s revision identifier changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov 403 Forbidden page.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error page instead of the study content; this indicates access to the study record is blocked at this URL.SummaryDifference0.5%

Stay in the know with updates to Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empa vs ACEi on Hyperfiltration: BETWEEN Clinical Trial page.